UNITED THERAPEUTICS Corp (UTHR) insider trading

By person

14 insiders · 2,827 transactions

145×

Martine Rothblatt holds 145 times base salary in stock. $225.43M of shares against $1.55M in salary for 2025.

Salary from the company's own proxy. The shares are what Martine Rothblatt last reported holding, valued at $602.72, the price Common Stock was last bought or sold at on the open market here, on 5 Nov 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Martine A Rothblatt

Chairperson & CEO

$863.95K (1)

$949.07M (2088) scheduled

−$948.20M

374,024

0.8720%

$225.43M

+6.9%

James Edgemond

CFO and Treasurer

—

$202.41M (375) scheduled

−$202.41M

18,876

0.0440%

$11.38M

+130.6%

Michael Benkowitz

President and COO

—

$168.77M (127) scheduled

−$168.77M

19,046

0.0444%

$11.48M

−83.8%

Paul A Mahon

EVP & General Counsel

—

$113.75M (203) scheduled

−$113.75M

45,172

0.1053%

$27.23M

+22.6%

Louis W Sullivan

Director

—

$3.05M (2) scheduled

−$3.05M

2,983

0.0070%

$1.80M

−79.8%

Christopher Patusky

Director

—

$2.73M (3) scheduled

−$2.73M

2,140

0.0050%

$1.29M

+137.8%

Tommy G Thompson

Director

—

$2.51M (5) scheduled

−$2.51M

8,480

0.0198%

$5.11M

0.0%

Ray Kurzweil

Director

—

$2.40M (1) scheduled

−$2.40M

13,320

0.0311%

$8.03M

+10.3%

Christopher Causey

Director

—

$2.33M (5) scheduled

−$2.33M

4,190

0.0098%

$2.53M

+21.4%

Judy D. Olian

Director

—

$417.00K (4) scheduled

−$417.00K

5,555

0.0130%

$3.35M

−25.0%

Jan Malcolm

Director

—

$373.41K (9) scheduled

−$373.41K

450

0.0010%

$271.22K

—

Nilda Mesa

Director

—

$355.54K (4)

−$355.54K

5,580

0.0130%

$3.36M

−7.1%

Richard Giltner

Director

—

21,884

0.0510%

$13.19M

+25.6%

Raymond Dwek

Director

—

1,750

0.0041%

$1.05M

0.0%

UNITED THERAPEUTICS Corp

What the insiders did Mostly scheduled

By person